KSR1 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HAP1 parental line, designed to disrupt the KSR1 gene. This polyclonal knockout model provides a robust loss-of-function resource for investigating KSR1-dependent signaling pathways in a near-haploid genetic background. The gene-edited population enables pooled functional analyses without single-cell clone selection, preserving population-level heterogeneity for experiments requiring biological replicates.
The HAP1 cell line is a human near-haploid cell model originally derived from the chronic myeloid leukemia cell line KBM-7. Characterized by an adherent phenotype and rapid proliferation, HAP1 cells are haploid for all chromosomes except chromosome 8, which is disomic. This near-haploid karyotype makes HAP1 an ideal platform for genetic screening and knockout studies, as single gene disruptions result in unambiguous loss-of-function phenotypes without interference from a second allele. The KSR1 knockout in this context thus offers a simplified system to dissect scaffold protein function.
KSR1 encodes a scaffolding protein that integrates Ras-mediated signals to promote the assembly of RAF?CMEK?CERK signaling complexes. Upon activation by upstream regulators such as EGF-bound receptor tyrosine kinases and Ras GTPases, KSR1 recruits RAF kinases, MEK1/2, and ERK1/2, and interacts with 14-3-3 proteins, IMP, HSP90, and CDC37 to facilitate efficient signal transduction. This scaffolding function enhances ERK1/2 phosphorylation and drives downstream transcriptional programs via factors including ELK1, c-Fos, c-Jun, and cyclin D1. Disruption of KSR1 impairs MAPK cascade activation, leading to attenuated cell proliferation and survival signaling.
In the HAP1 background, KSR1 knockout eliminates the scaffold essential for Ras-driven MAPK signaling, providing a clean loss-of-function model devoid of compensatory alleles. This polyclonal population is particularly valuable for studying Ras-dependent oncogenic mechanisms, given the cell line’s origin from chronic myeloid leukemia and its relevance to cancers such as melanoma and non-small cell lung cancer. The haploid nature allows straightforward interpretation of drug sensitivity, genetic interaction, and pathway epistasis experiments, circumventing issues of heterozygosity common in diploid models.
Researchers can employ these KSR1 knockout HAP1 polyclonal cells to dissect the MAPK pathway using techniques such as western blotting for phospho-ERK1/2, co-immunoprecipitation of KSR1-associated complexes, cell proliferation assays, and flow cytometry for cell cycle analysis. EGF stimulation time-course experiments and drug sensitivity profiling with MAPK pathway inhibitors further enable the study of scaffold-dependent drug resistance. These applications make the model suitable for cancer biology, Rasopathies research, and drug discovery efforts. For further information, please contact Ascent Research.
